Qualigen Therapeutics Inc (QLGN)

[The GidDy uP Kid]

...

[The GidDy uP Kid]

..

[The GidDy uP Kid]

.

[buckiii2]

https://www.prnewswire.com/news-releases/fda-approves-lumakras-sotorasib-the-first-and-only-targeted-treatment-for-patients-with-kras-g12c-mutated-locally-advanced-or-metastatic-non-small-cell-lung-cancer-301301808.html

[Atomic_joe]

I have question...I had some RTTR, still showing in my robinhood account. Was it supposed to transfer over to Qualigen?

[dirtydozen911]

didn`t spend too much time on the 10Q... quick scan i noticed technology transfer, october 2020 to YI XIN to manufacture and sell our "fastpack" diagnostic products in china, and after may 1st 2022 worldwide license to sell (except in U S A )....just marvelous!!!

can`t be bothered to look at the fins.....another company that "GAVE AWAY THE STORE" TO CHINA .....WTF

this explains why news out mid day and only up a few % on lousy volume...on a dow and nasd 300+ point day

this was trading at about $12 last august.....i`ll pass...gla

[Gentlemen Prefer Bonds]

So, QLGN cancelled this EUA that was going nowhere and all of the rookies from Reddit panicked and sold after hours Friday. They have been whining about the EUA for over a month. If the stock is weak on Monday's open, I'm adding to my position. I got in at $3.27 and out at $4.35. Back in again around $2.80, but looking to add on any weakness.

[wrenchit]

so why do this thing keep dropping whats up with this stock ?????

[2cutefeet]

Here is the link to the information regarding the CVR (Contingent Value Rights) as filed with the SEC: https://www.sec.gov/Archives/edgar/data/0001460702/000149315220000828/ex2-2.htm

[zmster2033]

I am a holder from the RTTR days. Does anyone know the requirements on the contingent value rights? TDA did not know what they were.

[wrenchit]

why is this page so dead nobody posting is this stock dead

[wrenchit]

good article this should be higher than it is i am buying at any lows

[Gentlemen Prefer Bonds]

Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL

https://finance.yahoo.com/news/qualigen-therapeutics-secures-option-negotiate-133000454.html

[wrenchit]

i really this that this can go somewhere i think bottom be like 3.50 pps then we move up and hopefully we will get more people looking at this stock

[Klinsmann]

Still on watch. No hurry to buy in, plus bears are all around this week

[wrenchit]

no body here dead board or not a hot stock ??

[Gentlemen Prefer Bonds]

We could use some news! I'm still long QLGN.

[Gentlemen Prefer Bonds]

Plus, QLGN has great management. Check out ichael Poirier's presentation at the H.C. Wainwright Bioconnect 2021 Conference last month. https://journey.ct.events/view/52bd06f2-13c4-4ad4-9772-90191e3a938a

[chainweight]

This stock is about to make a big move. Over 10% short, 20M outstanding, FDA EAU approval any day now for ten minute Covid test, and huge cancer killing products in the pipeline . One product skipped Phase 1 and went straight to Phase 2.

[chainweight]

You’re not, I’m here with you! Lol!

[Gentlemen Prefer Bonds]

Whoa! It looks like I was right! QLGN closed $3.87 up 0.54 (16.22%) today on 7 million shares. Great cancer and virus stuff in the pipeline. Too bad I'm talking to an empty room!

[Gentlemen Prefer Bonds]

It looks like QLGN is picking up momentum. I would love to see the stock close above $4.00

[Gentlemen Prefer Bonds]

**UPDATE**
New investor presentation
https://d1io3yog0oux5.cloudfront.net/_fa1dc0dd428f76bc11419c030647d797/qualigeninc/db/865/7399/pdf/Qualigen+Corporate+Presentation+Feb+2021.pdf


Michael S. Poirier presentation at the H.C. Wainwright BioConnect 2021 Virtual Conference January 11-14, 2021
https://journey.ct.events/view/52bd06f2-13c4-4ad4-9772-90191e3a938a

[stock1ace1]

Buying here

[Gentlemen Prefer Bonds]

QLGN at $3.27 is $0.25 lower than where the institutional investor bought it last week, and I'm out of money! I'd be a buyer, if I had cash. Their warrants strike at $4.07.

[ClayTrader]

* * $QLGN Video Chart 12-15-2020 * *

Link to Video - click here to watch the technical chart video

[0whammies]

Same date, time, scenario here. Avg'd in @ $5.03. Added later, up a little on the avg., but looking for a good return eventually. GL.

[RNsidersbuying]

July 13 2020 - We have already submitted notification to the U.S. Food and Drug Administration that we intend to commence commercial distribution of the SARS-CoV-2 IgG immunoassay test later this month.

Have we not received any 'robust' & 'synergistic' update on this small bit of information?

[abcxyz]

QLGNnew member on board from yahoo fiance https://finance.yahoo.com/news/qualigen-therapeutics-appoints-amy-broidrick-120000926.html" >https://finance.yahoo.com/news/qualigen-therapeutics-appoints-amy-broidrick-120000926.html

[peterus]

PRPO has to buy the test and are only for Labs
QLGN makes his on test
will see $30+ end of the year

[ShowMeThe$$$$$]

Bought QLGN on their announced shipping of test kits. But my excitement may have been premature. Press release says company has SUBMITTED kits to the FDA for Emergency Use Authorization while they commence sales.
Another company, PRPO made similar announcement about their test kits yesterday. The difference is their press release says their kits are already FDA APPROVED.
That’s a huge difference.

[peterus]

thanks

[abingo]

O/S 16.83m Float 4.46
After hrs. up 0.07 to $ 6.00

[peterus]

whats the O/S here ?

[Witch]

Been in this since 6am on July 1st had volume alert set on my webull account lol. Sell high, buy even more low. Accumulate. The time here is now. It's not past. It has just begun. Everyone here know about the bonus the execs here get for keeping SP above $15?

[zmster2033]

Hoping for a green week here this week!

[StockRoomBully]

Waitin...

[StockRoomBully]

Important wait....

[StockRoomBully]

Any news this fly pass cod* low float

[Klinsmann]

Good chance to turn, 4$ seems to establish as bottom

[StockRoomBully]

Welcome folks. What do ya think of this Gem?

[Klinsmann]

Same here

[nathanial]

On the radar screen.

[StockRoomBully]

Qualigen Therapeutics CEO Issues Letter to Stockholders

July 13 2020 - 08:00AM
PR Newswire (US) Print
CARLSBAD, Calif., July 13, 2020

/PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) ("Qualigen" or the "Company"), announced that today Chief Executive Officer Michael Poirier has issued a letter to Qualigen's stockholders. The full text of that letter is as follows:

To My Fellow Stockholders,

Many of you likely saw last week's exciting announcement that Qualigen Therapeutics raised $8 million in new capital.

In connection with this important development, I would like to provide some context as to how we expect to use those funds, and why we believe our plans will help build significant shareholder value.

We expect to advance the following key projects with existing cash resources and these new funds:

We plan to advance clinical trials with our pipeline of drug candidates for the treatment of certain cancers and infectious diseases. One of these drug candidates, AS1411, has been shown to be effective in halting the replication of viruses in proof-of-concept in vitro studies performed at the University of Louisville's prestigious Center for Infectious Disease, and could be used to treat patients who have COVID-19, the disease caused by the novel coronavirus SARS-CoV-2, as well as other similar viral-based diseases. We are aiming to commence a Phase 1 clinical trial of another of our drug candidates, ALAN, against acute myeloid leukemia in 2021.

We plan to continue to expand our pipeline of therapeutics, specifically in oncology through additional licenses and strategic relationships. We believe that having a robust and synergistic portfolio of potentially life-saving drugs is critical to building long-term shareholder value.
Finally, we plan to enhance the production automation our flagship FastPack® rapid diagnostic disposables and begin production of our new FastPack PRO analyzer, which is an upgraded version of our current FastPack IP analyzer. The test menu for FastPack PRO will include cFN, a new stroke assessment test being developed as a companion diagnostic for Prediction Sciences LLC, and our new SARS-CoV-2 IgG immunoassay test for COVID-19 antibodies. We have already submitted notification to the U.S. Food and Drug Administration that we intend to commence commercial distribution of the SARS-CoV-2 IgG immunoassay test later this month.

Overall, we believe these new funds will provide Qualigen with significant operational runway through calendar year 2021, allow us to build our team and product lines, and create new opportunities for the future benefit of Qualigen and our stockholders.

I extend thanks to you, our stockholders, and to everyone involved in this successful funding.

Sincerely,

Michael Poirier

President, Chief Executive Officer and Chairman

please visit https://www.qualigeninc.com/.

[StockRoomBully]

Early Bird get the first worm. lol

[StockMonster100]

Corporate execs to get BONUS

Its true....if the PPS can reach $8 and hold for 20 days. Bonus is activated

if it hits PPS of $15 and holds for 20 days, yet another round of Bonus



https://seekingalpha.com/filing/5042580#EX10-1_HTM

The country is running out of tests. They release there FDA approved test next week. Hold on for massive uptick


$$$ BULLISH $$$

[StockRoomBully]

One small step for mankind 2 Giant leap for Qualigen

[StockRoomBully]

Great potential here

[0whammies]

Not enough tests to go around....constant shortage.

[Mikems]

Hope so, but QLGN is dead money. RTTR flushes away money on lactose which can be treated already; antibodies for COVID-19 can be detected with current devices.